|
Commitments and Contingencies
|
9 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2014
|
||||
| Commitments and Contingencies Disclosure [Abstract] | ||||
| Commitments and Contingencies Disclosure [Text Block] |
Under the terms of the Settlement Agreement described in Note 6 – Significant Vendor above, the Company is obligated to engage Fraunhofer to perform at least $3 million of research and development work as directed by iBio by December 31, 2015. Effective January 31, 2014, the Company terminated a $1.5 million research services agreement with Fraunhofer. The Company had incurred $0.6 million in research and development expense related to such agreement. As of March 31, 2014, the Company had entered into research services agreements with Fraunhofer representing approximately $0.6 million of the $3 million commitment. |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for commitments and contingencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|